Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA

Hiroko Masuda1,2,3, Yuan Qi4, Shuying Liu1

  • 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Oncotarget
|October 21, 2017
PubMed
Abstract

Insights

Reverse phase protein array (RPPA) analysis identified two main subtypes of triple-negative breast cancer (TNBC): inflammation and hormonal-related (I/H) and DNA damage (DD)-related. These RPPA-based subtypes correlate with gene-expression subtypes, enhancing understanding of TNBC heterogeneity.

Area of Science:

  • Biomedical research
  • Cancer biology
  • Proteomics

Background:

  • Triple-negative breast cancer (TNBC) exhibits significant heterogeneity.
  • Reverse phase protein array (RPPA) enables functional protein-level target investigation.
  • This study uniquely integrates RPPA and mRNA analyses for TNBC subtyping.

Purpose of the Study:

  • To classify TNBC subtypes at the protein level using RPPA.
  • To compare RPPA-derived subtypes with established mRNA molecular subtypes.
  • To explore the functional proteomic basis of TNBC heterogeneity.

Main Methods:

  • RPPA analysis of 80 TNBC patient samples.
  • K-means and hierarchical consensus clustering for sample classification.
  • Ingenuity Pathway Analysis to identify key signaling pathways.
  • Comparison of RPPA-based clusters with TNBCtype, TNBCtype-4, and PAM50 mRNA subtypes.

Main Results:

  • Two biologically consistent clusters emerged: inflammation and hormonal-related (I/H) and DNA damage (DD)-related subtypes.
  • Key pathways identified include inflammation, hormonal receptors, MAPK signaling (I/H), and GADD45, DNA damage, p53 signaling (DD).
  • Five TNBC clusters were identified using k-means RPPA analysis, showing significant association with gene-expression-based TNBCtype molecular subtypes (p = 0.017).

Conclusions:

  • RPPA analysis successfully identified distinct I/H and DD subtypes in TNBC.
  • These findings provide a functional proteomic perspective on TNBC heterogeneity.
  • The identified subtypes offer potential for refined TNBC classification and targeted therapies.

Related Concept Videos